{"database": "lobbying", "table": "lobbying_activities", "rows": [[784223, "daa597b7-b5da-482d-b2fb-18b157e8fd0c", "Q2", "PRIME THERAPEUTICS", 400339576, "PRIME THERAPEUTICS", 2009, "second_quarter", "INS", "HR 1204 \"Community Pharmacy Fairness Act of 2009\"\nS._____  \"Affordable Health Choices Act\"\nHealth care reform - follow-on biologics, pharmaceutical benefits, comparative effectiveness, public plan option, drug pricing, generic pharmaceuticals, Health IT, Medicare Part D, medicaid, Medicare Part D HR 1427/S 726 \"Promoting Innovation and Access to Life-saving Medicine Act\"\nHR 1548 \"Pathway for Biosimilars Act\"\nMedicare Part D", "Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office", null, 106701, 0, 0, "2009-07-09T14:32:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["784223"], "units": {}, "query_ms": 66.16465200204402, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}